Matches in SemOpenAlex for { <https://semopenalex.org/work/W2561000739> ?p ?o ?g. }
- W2561000739 endingPage "12" @default.
- W2561000739 startingPage "1" @default.
- W2561000739 abstract "IgE is an immunoglobulin that plays a central role in acute allergic reactions and chronic inflammatory allergic diseases. The development of a drug able to neutralize this antibody represents a breakthrough in the treatment of inflammatory pathologies with a probable allergic basis. This review focuses on IgE-related chronic diseases, such as allergic asthma and chronic urticaria (CU), and on the role of the anti-IgE monoclonal antibody, omalizumab, in their treatment. We also assess the off-label use of omalizumab for other pathologies associated with IgE and report the latest findings concerning this drug and other new related drugs. To date, omalizumab has only been approved for severe allergic asthma and unresponsive chronic urticaria treatments. In allergic asthma, omalizumab has demonstrated its efficacy in reducing the dose of inhaled corticosteroids required by patients, decreasing the number of asthma exacerbations, and limiting the effect on airway remodeling. In CU, omalizumab treatment rapidly improves symptoms and in some cases achieves complete disease remission. In systemic mastocytosis, omalizumab also improves symptoms and its prophylactic use to prevent anaphylactic reactions has also been discussed. In other pathologies such as atopic dermatitis, food allergy, allergic rhinitis, nasal polyposis, and keratoconjunctivitis, omalizumab significantly improves clinical manifestations. Omalizumab acts in two ways: by sequestering free IgE and by accelerating the dissociation of the IgE-Fc ε receptor I complex." @default.
- W2561000739 created "2017-01-06" @default.
- W2561000739 creator A5021426383 @default.
- W2561000739 creator A5030327076 @default.
- W2561000739 creator A5049021741 @default.
- W2561000739 creator A5070221368 @default.
- W2561000739 date "2016-01-01" @default.
- W2561000739 modified "2023-10-15" @default.
- W2561000739 title "IgE-Related Chronic Diseases and Anti-IgE-Based Treatments" @default.
- W2561000739 cites W136702448 @default.
- W2561000739 cites W1498671792 @default.
- W2561000739 cites W1512622009 @default.
- W2561000739 cites W1533977973 @default.
- W2561000739 cites W1558545064 @default.
- W2561000739 cites W1569638557 @default.
- W2561000739 cites W1574666144 @default.
- W2561000739 cites W1587619175 @default.
- W2561000739 cites W1656622090 @default.
- W2561000739 cites W1773647412 @default.
- W2561000739 cites W1828975699 @default.
- W2561000739 cites W1835232554 @default.
- W2561000739 cites W1838314930 @default.
- W2561000739 cites W1887965535 @default.
- W2561000739 cites W1923203539 @default.
- W2561000739 cites W1954051586 @default.
- W2561000739 cites W1969177745 @default.
- W2561000739 cites W1971723752 @default.
- W2561000739 cites W1974217538 @default.
- W2561000739 cites W1975373828 @default.
- W2561000739 cites W1976982560 @default.
- W2561000739 cites W1983840607 @default.
- W2561000739 cites W1985017750 @default.
- W2561000739 cites W1985748428 @default.
- W2561000739 cites W1987553199 @default.
- W2561000739 cites W1992103497 @default.
- W2561000739 cites W1994733035 @default.
- W2561000739 cites W1996855351 @default.
- W2561000739 cites W2000668449 @default.
- W2561000739 cites W2001207600 @default.
- W2561000739 cites W2005401546 @default.
- W2561000739 cites W2009608314 @default.
- W2561000739 cites W2013105339 @default.
- W2561000739 cites W2015409726 @default.
- W2561000739 cites W2020436479 @default.
- W2561000739 cites W2021701428 @default.
- W2561000739 cites W2024045584 @default.
- W2561000739 cites W2025003624 @default.
- W2561000739 cites W2025546025 @default.
- W2561000739 cites W2026119244 @default.
- W2561000739 cites W2031029516 @default.
- W2561000739 cites W2034866086 @default.
- W2561000739 cites W2038199642 @default.
- W2561000739 cites W2039252747 @default.
- W2561000739 cites W2041791106 @default.
- W2561000739 cites W2055349211 @default.
- W2561000739 cites W2059540883 @default.
- W2561000739 cites W2061435251 @default.
- W2561000739 cites W2061452912 @default.
- W2561000739 cites W2064547094 @default.
- W2561000739 cites W2065357866 @default.
- W2561000739 cites W2068972960 @default.
- W2561000739 cites W2069807842 @default.
- W2561000739 cites W2072685431 @default.
- W2561000739 cites W2073364837 @default.
- W2561000739 cites W2074710101 @default.
- W2561000739 cites W2077553000 @default.
- W2561000739 cites W2077819583 @default.
- W2561000739 cites W2078966393 @default.
- W2561000739 cites W2085071459 @default.
- W2561000739 cites W2085255857 @default.
- W2561000739 cites W2087196444 @default.
- W2561000739 cites W2089505012 @default.
- W2561000739 cites W2092035613 @default.
- W2561000739 cites W2096008082 @default.
- W2561000739 cites W2098174030 @default.
- W2561000739 cites W2098276532 @default.
- W2561000739 cites W2098498859 @default.
- W2561000739 cites W2101965993 @default.
- W2561000739 cites W2102629488 @default.
- W2561000739 cites W2103779502 @default.
- W2561000739 cites W2105880697 @default.
- W2561000739 cites W2109455334 @default.
- W2561000739 cites W2109951782 @default.
- W2561000739 cites W2109958057 @default.
- W2561000739 cites W2112898002 @default.
- W2561000739 cites W2115268249 @default.
- W2561000739 cites W2119346099 @default.
- W2561000739 cites W2120901603 @default.
- W2561000739 cites W2121663010 @default.
- W2561000739 cites W2125206676 @default.
- W2561000739 cites W2128897354 @default.
- W2561000739 cites W2131758520 @default.
- W2561000739 cites W2137002319 @default.
- W2561000739 cites W2138814764 @default.
- W2561000739 cites W2140909066 @default.
- W2561000739 cites W2141701917 @default.
- W2561000739 cites W2143120339 @default.
- W2561000739 cites W2152833994 @default.